![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 52, 54248-54257, December 24, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B Activation by Peptides Targeting NF-
B Essential Modulator (NEMO) Oligomerization*





From the
Unité de Régulation Enzymatique des Activités Cellulaires, CNRS URA 2185, ¶Unité de Biologie Moléculaire de l'Expression Génique, CNRS URA 2582, and **Unité de Chimie Organique, CNRS URA 2128, Institut Pasteur, 25/28 rue du Dr. Roux 75724 Paris cedex 15 France
NF-
B essential modulator/IKK-
(NEMO/IKK-
) plays a key role in the activation of the NF-
B pathway in response to proinflammatory stimuli. Previous studies suggested that the signal-dependent activation of the IKK complex involves the trimerization of NEMO. The minimal oligomerization domain of this protein consists of two coiled-coil subdomains named Coiled-coil 2 (CC2) and leucine zipper (LZ) (Agou, F., Traincard, F., Vinolo, E., Courtois, G., Yamaoka, S., Israel, A., and Veron, M. (2004) J. Biol. Chem. 279, 2786127869). To search for drugs inhibiting NF-
B activation, we have rationally designed cell-permeable peptides corresponding to the CC2 and LZ subdomains that mimic the contact areas between NEMO subunits. The peptides were tagged with the Antennapedia/Penetratin motif and delivered to cells prior to stimulation with lipopolysaccharide. Peptide transduction was monitored by fluorescence-activated cell sorter, and their effect on lipopolysaccharide-induced NF-
B activation was quantified using an NF-
B-dependent
-galactosidase assay in stably transfected pre-B 70Z/3 lymphocytes. We show that the peptides corresponding to the LZ and CC2 subdomains inhibit NF-
B activation with an IC50 in the µM range. Control peptides, including mutated CC2 and LZ peptides and a heterologous coiled-coil peptide, had no inhibitory effect. The designed peptides are able to induce cell death in human retinoblastoma Y79 cells exhibiting constitutive NF-
B activity. Our results provide the "proof of concept" for a new and promising strategy for the inhibition of NF-
B pathway activation through targeting the oligomerization state of the NEMO protein.
Received for publication, June 9, 2004 , and in revised form, October 1, 2004.
* This work was supported in by grants from "the Association pour la Recherche sur le Cancer" (ARC Grant number 5795), the Ligue Nationale contre le Cancer (équipe labelisée) (to A. I.), and the Direction de la Valorisation et des Partenariats Industriels at the Pasteur Institut. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| Present address: INSERM U532, Hôpital Saint-Louis, 75475 Paris cedex France.
To whom correspondence should be addressed. Tel.: 33-1-44-38-95-69; Fax: 33-1-45-68-83-99; E-mail: fagou{at}pasteur.fr.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Palkowitsch, J. Leidner, S. Ghosh, and R. B. Marienfeld Phosphorylation of Serine 68 in the I{kappa}B Kinase (IKK)-binding Domain of NEMO Interferes with the Structure of the IKK Complex and Tumor Necrosis Factor-{alpha}-induced NF-{kappa}B Activity J. Biol. Chem., January 4, 2008; 283(1): 76 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wyler, M. Kaminska, Y.-M. Coic, F. Baleux, M. Veron, and F. Agou Inhibition of NF-{kappa}B activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO Protein Sci., September 1, 2007; 16(9): 2013 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hong, L.-C. Wang, X. Gao, Y.-L. Kuo, B. Liu, R. Merling, H.-J. Kung, H.-M. Shih, and C.-Z. Giam Heptad Repeats Regulate Protein Phosphatase 2A Recruitment to I-{kappa}B Kinase {gamma}/NF-{kappa}B Essential Modulator and Are Targeted by Human T-lymphotropic Virus Type 1 Tax J. Biol. Chem., April 20, 2007; 282(16): 12119 - 12126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Marienfeld, L. Palkowitsch, and S. Ghosh Dimerization of the I{kappa}B Kinase-Binding Domain of NEMO Is Required for Tumor Necrosis Factor Alpha-Induced NF-{kappa}B Activity Mol. Cell. Biol., December 15, 2006; 26(24): 9209 - 9219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Y. Chang, L. Zsak, Y. Feng, R. Mosseri, Q. Lu, P. Kowalski, A. Zsak, T. G. Burrage, J. G. Neilan, G. F. Kutish, et al. Phenotype-based identification of host genes required for replication of african Swine Fever virus. J. Virol., September 1, 2006; 80(17): 8705 - 8717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Girvan, Y. Teng, L. K. Casson, S. D. Thomas, S. Juliger, M. W. Ball, J. B. Klein, W. M. Pierce Jr., S. S. Barve, and P. J. Bates AGRO100 inhibits activation of nuclear factor-{kappa}B (NF-{kappa}B) by forming a complex with NF-{kappa}B essential modulator (NEMO) and nucleolin. Mol. Cancer Ther., July 1, 2006; 5(7): 1790 - 1799. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |